patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Very plausable thought from yahoo -

Re: Huge Demand encourages Underwriters boost Pluristem offering to $41m 31-Jan-11 11:59 am

This offering will close tomorrow. After that I expect analyst upgrades as this stock has room to run!
Share
New Message
Please login to post a reply